| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 317.52K | 317.52K | 44.05K | 16.15K | 38.74K | 0.00 |
| Gross Profit | -8.32M | -3.01M | -8.98M | -983.56K | -141.27K | -47.19K |
| EBITDA | -38.01M | -28.91M | -22.80M | -16.26M | -14.23M | -17.12M |
| Net Income | -32.56M | -32.56M | -24.98M | -15.68M | -7.36M | -16.27M |
Balance Sheet | ||||||
| Total Assets | 283.37M | 283.37M | 267.30M | 67.11M | 54.56M | 51.97M |
| Cash, Cash Equivalents and Short-Term Investments | 102.04M | 102.04M | 189.62M | 20.59M | 16.83M | 50.34M |
| Total Debt | 4.42M | 4.42M | 3.69M | 338.81K | 537.59K | 56.61K |
| Total Liabilities | 64.50M | 64.50M | 20.12M | 11.10M | 7.69M | 1.69M |
| Stockholders Equity | 218.88M | 218.88M | 247.17M | 56.02M | 46.87M | 50.28M |
Cash Flow | ||||||
| Free Cash Flow | -103.78M | -106.48M | -47.75M | -35.50M | -34.95M | -8.36M |
| Operating Cash Flow | -18.24M | -18.24M | -22.42M | -11.29M | -3.76M | -1.63M |
| Investing Cash Flow | -69.39M | -69.39M | -25.13M | -8.00M | -31.14M | -6.71M |
| Financing Cash Flow | -367.52K | -367.52K | 216.58M | 23.07M | 1.39M | 50.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | AU$760.20M | 13.60 | 15.33% | ― | 6.70% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
51 Neutral | AU$439.98M | 3.21 | 145.87% | ― | 45.56% | ― | |
48 Neutral | AU$570.64M | -32.58 | -7.50% | ― | ― | 51.47% | |
46 Neutral | AU$2.23B | -34.83 | -50.19% | ― | ― | -20.85% | |
45 Neutral | AU$952.97M | -29.02 | -13.97% | ― | 620.73% | -21.19% | |
44 Neutral | AU$453.67M | -16.55 | -45.39% | ― | ― | -91.89% |
Alpha HPA Limited announced a change in the director’s interest following the vesting of performance rights for directors Marghanita Johnson and Annie Liu. This change reflects the conversion of performance rights into fully paid ordinary shares, indicating a potential positive outlook for the company’s leadership and alignment with shareholder interests.
The most recent analyst rating on (AU:A4N) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Alpha HPA Limited stock, see the AU:A4N Stock Forecast page.
Alpha HPA Limited has announced the quotation of 3,640,000 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code A4N, effective December 15, 2025. This move is part of the company’s broader strategy to enhance its market presence and operational capacity, potentially impacting its industry positioning by increasing its financial flexibility and shareholder value.
The most recent analyst rating on (AU:A4N) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Alpha HPA Limited stock, see the AU:A4N Stock Forecast page.
Alpha HPA Limited announced a change in director’s interest notices following the approval and partial vesting of Performance Rights at its recent Annual General Meeting. This update reflects the company’s ongoing governance and incentive strategies, potentially impacting shareholder perceptions and director alignment with company performance.
The most recent analyst rating on (AU:A4N) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Alpha HPA Limited stock, see the AU:A4N Stock Forecast page.
Alpha HPA Limited has announced the quotation of 371,172 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code A4N. This move reflects the company’s strategic efforts to enhance its market presence and operational capacity, potentially impacting its industry positioning by increasing its available capital and shareholder base.
The most recent analyst rating on (AU:A4N) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Alpha HPA Limited stock, see the AU:A4N Stock Forecast page.
Alpha HPA Limited has announced the issuance of unquoted equity securities in the form of performance rights, with a total of 2,034,557 securities issued. This move is part of an employee incentive scheme, highlighting the company’s commitment to aligning employee interests with corporate goals. The issuance of these securities is expected to strengthen Alpha HPA’s operational framework and enhance its competitive positioning in the advanced materials sector.
The most recent analyst rating on (AU:A4N) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Alpha HPA Limited stock, see the AU:A4N Stock Forecast page.
Alpha HPA Limited announced that all resolutions proposed at its Annual General Meeting were passed successfully, indicating strong shareholder support for the company’s strategic direction and governance. This outcome reinforces the company’s stability and commitment to its stakeholders, potentially enhancing its market position and operational confidence.
The most recent analyst rating on (AU:A4N) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Alpha HPA Limited stock, see the AU:A4N Stock Forecast page.
Alpha HPA Limited has conducted a Definitive Feasibility Study (DFS) to evaluate the HPA First project’s technical and financial feasibility. The study indicates that additional funding is required to achieve the desired outcomes, and there is uncertainty about securing this funding. The company may consider alternative strategies such as a sale or joint venture, which could affect its ownership stake in the project.
The most recent analyst rating on (AU:A4N) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Alpha HPA Limited stock, see the AU:A4N Stock Forecast page.
Alpha HPA Limited announced the issuance of 20 million unquoted options set to expire on October 31, 2029, with an exercise price of $1.00. This move is part of previously announced transactions and reflects the company’s strategic efforts to enhance its financial flexibility and support its long-term growth initiatives.
The most recent analyst rating on (AU:A4N) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Alpha HPA Limited stock, see the AU:A4N Stock Forecast page.
Alpha HPA Limited has made significant progress in its HPA First Project, particularly in Stage 2, which is set to become the world’s largest facility for high purity aluminium materials. The company is seeing strong demand from the semiconductor sector, driven by its unique ability to deliver products with zero uranium/thorium content. With ongoing construction and new contracts in negotiation, Alpha HPA is well-positioned to meet future demand and expand its market presence.
The most recent analyst rating on (AU:A4N) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Alpha HPA Limited stock, see the AU:A4N Stock Forecast page.
Alpha HPA Limited has announced a proposed issue of 20 million new securities, specifically options expiring on October 31, 2029, with an exercise price of $1.00. This move is part of the company’s strategic efforts to raise capital, potentially enhancing its market position and supporting its growth initiatives in the advanced materials sector.
The most recent analyst rating on (AU:A4N) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Alpha HPA Limited stock, see the AU:A4N Stock Forecast page.
Alpha HPA Limited has released its Annual Report for the fiscal year ending June 30, 2025, and announced its upcoming Annual General Meeting scheduled for November 24, 2025. This announcement provides stakeholders with insights into the company’s financial performance and strategic direction, reinforcing its commitment to transparency and shareholder engagement.
The most recent analyst rating on (AU:A4N) stock is a Buy with a A$2.00 price target. To see the full list of analyst forecasts on Alpha HPA Limited stock, see the AU:A4N Stock Forecast page.